购物车
- 全部删除
- 您的购物车当前为空
MDK6465, also known as PCSK9-IN-8b, is a novel liver-targeted inhibitor of ribosomal synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9). MDK6465 has CAS#1900686-46-5. the last 4 digits are used in its name.
MDK6465, also known as PCSK9-IN-8b, is a novel liver-targeted inhibitor of ribosomal synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9). MDK6465 has CAS#1900686-46-5. the last 4 digits are used in its name.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 19,400 | 10-14周 | |
50 mg | ¥ 25,800 | 10-14周 | |
100 mg | ¥ 33,500 | 10-14周 |
产品描述 | MDK6465, also known as PCSK9-IN-8b, is a novel liver-targeted inhibitor of ribosomal synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9). MDK6465 has CAS#1900686-46-5. the last 4 digits are used in its name. |
分子量 | 598.03 |
分子式 | C27H29ClFN9O4 |
CAS No. | 1900686-46-5 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容